Mkts

OptimizeRx Corporation

NASDAQ: OPRX
$9.15+0.07 (+0.77%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
8.899.31
52-week range
4.5422.25
Today
Open9.08
Previous close9.15
Volume—
Valuation
Market cap172.35M
P/E ratio37.46×
EPS (TTM)0.24
Income & risk
Dividend / yield—
Beta1.16
Avg volume258.3K
Discussion

OPRX News

Stories mentioning OPRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue19,84432,23926,06729,19521,92832,31621,30918,812
Cost of Goods Sold4,9128,1398,55110,5608,58410,2937,8627,108
Gross Profit14,93224,10017,51618,63513,34422,02313,44711,704
Operating Expenses
Research & Development3,4023,252
Sales General & Admin
Total Operating Expenses15,53215,46615,44615,45818,38922,00915,453
Operating Income (Loss)396.008,5562,0503,189(2,102)3,634(8,562)(3,749)
Interest Income77.0084.0091.0090.0088.0096.00107.00106.00
Interest Expense
Other Expense
Pretax Income(644.00)7,4601,0491,713(3,272)2,207(9,941)(5,096)
Tax Provision(149.00)2,440270.00181.00(1,073)2,286(817.00)(1,088)
Net Income (Loss)(495.00)5,020779.001,532(2,199)(78.00)(9,124)(4,008)
Earnings Per Share (Basic)(0.03)0.270.040.08(0.12)0.00(0.50)(0.22)
Earnings Per Share (Diluted)(0.03)0.260.040.08(0.12)0.00(0.50)(0.22)
Weighted Average Shares Outstanding (Basic)18,76218,55518,57618,51118,47118,29318,32418,258
Weighted Average Shares Outstanding (Diluted)18,76218,99819,46019,01518,47118,29318,32418,258

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About OPRX

OptimizeRx Corporation (NASDAQ: OPRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol OPRX. It last traded at $9.15 (Oct 23, 2026, 4:00 PM ET), up 0.8% on the day. That gives OptimizeRx a market capitalisation of $172.3M and a price-to-earnings ratio of 37.5.

Over the past 52 weeks OPRX has traded between $4.54 and $22.25.

Revenue for the quarter ended Mar 31, 2026 was $19.8M; a net loss of $495.0K. Revenue was down 9.5% from $21.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$19.8M-$495.0K-2.5%
Dec 31, 2025$32.2M$5.0M15.6%
Sep 30, 2025$26.1M$779.0K3.0%
Jun 30, 2025$29.2M$1.5M5.2%

From OptimizeRx’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…